BPC-157 + TB-500, for the cartilage indication Due to the emerging chondroprotective profile of AOD-9604 (Vukmirovic-Popovic 2010), the research literature features the combination with BPC-157 and TB-500 for indications: Osteoarthritis (intra-articular formulation) Tendinopathy Chondral defects in animal models MOTS-c, metabolic support MOTS-c improves mitochondrial efficiency, released fatty acids from AOD-9604-induced lipolysis can then be more efficiently oxidized
Nat Metab 2021 (single-nuclei RNA-seq)
Simple timing framework Baseline Discuss baseline labs before starting, especially if there is active injury, gut symptoms, infection concern, liver disease, kidney disease, or medication use
However, when combined with insulin or sulfonylureas, the risk of hypoglycemia increases substantially, potentially affecting twenty to thirty percent of patients if doses of concurrent medications are not appropriately adjusted